GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

Clinical trial NCT07221214 · RECRUITING

Trial details

NCT number: NCT07221214
Sponsor: Vanderbilt University Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Alcohol Smoking Cigarette Cardiovascular Disease Prevention

Start date: 2026-04-17
Primary completion: 2029-10-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.